Air Filtration for COPD in VA Population of Veterans

Illinois Institute of Technology

Status: Active, not recruiting

Conditions: Pulmonary Disease, Chronic Obstructive

Treatments: Device: Air cleaner

Study type: Interventional

Funder types: Other; Other U.S. Federal agency

Identifiers

NCT05913765

ILHHU0049-19 (Other Grant/Funding Number)

irb-2022-92

IRB #1675992 (Other Identifier)

Details and patient eligibility

About

The goal of this study is to investigate the effectiveness of stand-alone air filtration for improving indoor air quality (IAQ) and chronic obstructive pulmonary disease (COPD) outcomes in a high-risk urban cohort of 80 U.S. military veterans with COPD. Secondary goals of the study are to (1) investigate housing-related factors that may contribute to COPD exacerbation, (2) investigate the utility of using low-cost sensors for indoor air pollution epidemiology studies and for providing actionable or useful information on the quality of their indoor air to patients and their physicians, and (3) evaluate the costs and benefits of using stand-alone air filtration to improve IAQ and COPD outcomes.

Full description

The study will utilize a randomized, single-blind, placebo-controlled case-control design in which stand-alone portable air cleaners will be introduced to the study population over a period of approximately 1 year. One-half of the study population (40 participants) will receive a normally functioning filtration unit (i.e., an air cleaner with HEPA filter installed) and one-half of the study population (40 participants) will receive a placebo filtration unit (i.e., an air cleaner with the primary filter removed). The participants will be blinded; they will not know the status of the filter. Stand-alone portable air cleaning units containing HEPA filters and high clean air delivery rates (CADRs) sufficiently sized for the spaces they will serve will be used. The study will also involve housing condition assessments conducted in each home to characterize housing-related factors that may contribute to COPD exacerbation at baseline, as well as measurements of indoor and outdoor air quality and environmental conditions, and records of clinical outcomes (e.g., COPD exacerbations, emergency room visits, 6-minute walk distance, oxygen saturation, etc. accessed through the subject's VA medical record) throughout the study duration. The validated and extensively used St. George's Respiratory Questionnaire (SGRQ-C) and Veterans RAND 36-Item Health Survey (VR-36) will be used to determine health-related quality of life (HR-QoL) of participants by the JBVAMC Study Personnel. Clinical outcomes will also be used to assess costs of care with and without filtration interventions in this population. Low-cost air quality sensors will be used to monitor IAQ for the duration of the study). The study will also evaluate the upfront costs and operational and maintenance costs of the air cleaners over the course of the intervention periods and will compare them to the expected impacts on costs of care both with and without filtration interventions in this population.

Enrollment: 80 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age: 18 - 90+ years.
2. English speaking and writing.
3. Able to provide consent.
4. Resident of Chicago metropolitan area.
5. Veteran receiving health care at JBVAMC with a documented diagnosis of COPD.
6. Stable housing for at least 6 months prior to screening.
7. Able to communicate regularly by telephone.

Exclusion criteria

1. Home palliative care.
2. Life expectancy <6 months.
3. Hazardous conditions and/or safety concerns in or around the veteran's household
4. Screened patients that already have an air cleaner and alike in his/her current residence
5. Concomitant operation of a non-study air cleaner and alike by a participant in his/her current residence at any time during the course of the trial constitutes protocol violation leading to disqualification of said participant from the study.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

80 participants in 2 patient groups, including a placebo group

Intervention

Active Comparator group

Description:

an air cleaner with HEPA and carbon filter installed

Treatment:

Device: Air cleaner

Placebo

Placebo Comparator group

Description:

an air cleaner with the primary filter removed

Treatment:

Device: Air cleaner